Attending rounds: A patient with drug-resistant hypertension

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 9, 2011, Pages 2301-2306

  Townsend, Raymond R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; CATECHOLAMINE; CLONIDINE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FENOFIBRATE; HYDROCHLOROTHIAZIDE; METFORMIN; METOPROLOL; SIMVASTATIN; VALSARTAN;

ADRENAL MEDULLA; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BLOOD PRESSURE VARIABILITY; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; FATIGUE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; MEDICAL SOCIETY; NON INSULIN DEPENDENT DIABETES MELLITUS; PLASMA RENIN ACTIVITY; SEDENTARY LIFESTYLE; SODIUM RESTRICTION; SYSTOLIC BLOOD PRESSURE; TREATMENT RESPONSE; URINALYSIS; WEIGHT REDUCTION; XEROSTOMIA;

DIET, SODIUM-RESTRICTED; DRUG RESISTANCE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; REFERRAL AND CONSULTATION; TEACHING ROUNDS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 80052556812     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.04120511     Document Type: Article

References (20)

1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ: Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42: 1206-1252, 2003
2. de la Sierra A, Segura J, Banegas JR, Gorostidi M, de la Cruz JJ, Armario P, Oliveras A, Ruilope LM: Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. American Journal of Hypertension 57: 898-902, 2011
3. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, White A, Cushman WC, White W, Sica D, Ferdinand K, Giles TD, Falkner B, Carey RM: Resistant hypertension: Diagnosis, evaluation, and treatment: A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation 117: e510-e526, 2008
4. Brown MA, Buddle ML, Martin A: Is resistant hypertension really resistant? Am J Hypertens 14: 1263-1269, 2001
5. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz T, Sheps SG, Roccella EJ: Recommendations for blood pressure measurement in humans and experimental animals: Part 1: Blood pressure measurement in humans: A statement for professionals from the subcommittee of professional and public education of the American Heart Association Council on High Blood Pressure Research. Circulation 111: 697-716, 2005
6. Pimenta E, Gaddam KK, Oparil S, Aban I, Husain S, Dell'Italia LJ, Calhoun DA: Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: Results from a randomized trial. Hypertension 54: 475-481, 2009
7. Manni R, Politini L, Ratti MT, Tartara A: Sleepiness in obstructive sleep apnea syndrome and simple snoring evaluated by the Epworth Sleepiness Scale. J Sleep Res 8: 319-320, 1999
8. Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A, Daniels S, Floras JS, Hunt CE, Olson LJ, Pickering TG, Russell R, Woo M, Young T: Sleep apnea and cardiovascular disease: An American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. J Am Coll Cardiol 52: 686-717, 2008
9. Carey RM: Primary aldosteronism. Horm Res 71[Suppl 1]: 8-12, 2009
10. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young WF Jr, Montori VM: Case detection, diagnosis, and treatment of patients with primary aldosteronism: An endocrine society clinical practice guideline. J Clin Endocrinol Metab 93: 3266-3281, 2008
11. Mackenzie IS, Brown MJ: Molecular and clinical investigations in patients with low-renin hypertension. Clin Exp Nephrol 13: 1-8, 2009
12. Pacak K, Linehan WM, Eisenhofer G, Walther MM, Goldstein DS: Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma. Ann Intern Med 134: 315-329, 2001
13. Townsend RR, Cirigliano M: Hypertension in renal failure. Dis Mon 44: 243-253, 1998
14. Lip GY, Beevers M, Beevers DG: The "Birmingham Hypertension Square" for the optimum choice of add-in drugs in the management of resistant hypertension. J Hum Hypertens 12: 761-763, 1998
15. Chapman N, Dobson J, Wilson S, Dahlof B, Sever PS, Wedel H, Poulter NR: Effect of spironolactone on blood pressure in subjects with resistant hypertension. Hypertension 49: 839-845, 2007
16. Sakamoto H, Ichikawa S, Sakamaki T, Nakamura T, Ono Z, Takayama Y, Murata K: Time-related changes in plasma adrenal steroids during treatment with spironolactone in primary aldosteronism. American Journal of Hypertension 3: 533-537, 1990
17. Scheffers IJ, Kroon AA, Schmidli J, Jordan J, Tordoir JJ, Mohaupt MG, Luft FC, Haller H, Menne J, Engeli S, Ceral J, Eckert S, Erglis A, Narkiewicz K, Philipp T, De Leeuw PW: Novel baroreflex activation therapy in resistant hypertension: Results of a European multi-center feasibility study. J Am Coll Cardiol 56: 1254-1258, 2010
18. Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Bohm M: Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): A randomised controlled trial. Lancet 376: 1903-1909, 2010
19. Moser M, Setaro JF: Clinical practice. Resistant or difficult-tocontrol hypertension. N Engl J Med 355: 385-392, 2006
20. Green BB, Ralston JD, Fishman PA, Catz SL, Cook A, Carlson J, Tyll L, Carrell D, Thompson RS: Electronic Communications and Home Blood Pressure Monitoring (e-BP) Study: Design, delivery, and evaluation framework. Contemp Clin Trials 29: 376-395, 2008